{
    "relation": [
        [
            "",
            "Treatment-naive Patients",
            "Pre-treated Patients With Baseline HIV RNA <50 Copies/ml",
            "Pre-treated Patients With Baseline HIV RNA>=50 Copies/ml",
            "Pre-treated Patients With Baseline HIV RNA Not Documented"
        ],
        [
            "Description",
            "Patient was not treated with any antiretroviral drugs (ARV) before start of therapy with Viramune",
            "Baseline reflects the last available documentation before start of treatment with Viramune",
            "Baseline reflects the last available documentation before start of treatment with Viramune",
            "Baseline reflects the last available documentation before start of treatment with Viramune"
        ]
    ],
    "pageTitle": "Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune - Study Results - ClinicalTrials.gov",
    "title": "",
    "url": "https://clinicaltrials.gov/ct2/show/results/NCT00979420?sect=Xl0156&view=results",
    "hasHeader": true,
    "headerPosition": "MIXED",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042990112.50/warc/CC-MAIN-20150728002310-00092-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 851445771,
    "recordOffset": 851432381,
    "tableOrientation": "VERTICAL",
    "textBeforeTable": "Reporting Groups No text entered. Significant events and approaches for the overall study following participant enrollment, but prior to group assignment Pre-Assignment Details No text entered. Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations Recruitment Details \u00a0 Hide Participant Flow \u00a0 Participant Flow HIV Infections Condition: Time\u00a0Perspective:\u00a0Retrospective Study Design: Observational Study Type: How to Read a Study Record Disclaimer Study Results Tabular Results First Received: May 30, 2012 \u00a0",
    "textAfterTable": "Participant Flow: \u00a0 Overall Study \u00a0 \u00a0 Treatment-naive Patients \u00a0 \u00a0 Pre-treated Patients With Baseline HIV RNA <50 Copies/ml \u00a0 \u00a0 Pre-treated Patients With Baseline HIV RNA>=50 Copies/ml \u00a0 \u00a0 Pre-treated Patients With Baseline HIV RNA Not Documented \u00a0 STARTED \u00a0 \u00a0 178 \u00a0 \u00a0 57 \u00a0 \u00a0 60 \u00a0 \u00a0 61 \u00a0 COMPLETED \u00a0 \u00a0 171 \u00a0 \u00a0 57 \u00a0 \u00a0 59 \u00a0 \u00a0 59 \u00a0 NOT COMPLETED \u00a0 \u00a0 7 \u00a0 \u00a0 0 \u00a0 \u00a0 1 \u00a0 \u00a0 2 \u00a0 Adverse Event \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 1 \u00a0",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}